KOREA WHO
-
-
-
CEO of Naturecell
Byun Dae-jung
Lawyer-Turned Executive, Tackles Global Expansion of ‘Jointstem’
-
Last Updated on Apr 18, 2025
-
CEO of Naturecell
Life Summary
Byun Dae-jung is the CEO of Naturecell.
He is focusing on expanding the global market for the stem cell therapy “JointStem” following its designation as an “innovative therapy” by the U.S. FDA.
He was born on January 26, 1973.
He graduated from the Department of Law at Kyonggi University.
He worked as a partner attorney at Chun Chu Law Firm and joined Naturecell in 2020 as the head of legal affairs.
After the company’s owner and former CEO, Ra Jung-chan, stepped down from management, he has been leading the company together with co-CEO Kim Ju-sun.
In December 2024, he was appointed as the sole CEO of Naturecell.
As a professional manager with a background in law, he enjoys strong trust from Ra Jung-chan.
#Naturecell #ByunDaejung #stemcelltherapy #JointStem #USFDA #biotech #CEO #RaJungchan #KyonggiUniversity #lawyerCEO
He is focusing on expanding the global market for the stem cell therapy “JointStem” following its designation as an “innovative therapy” by the U.S. FDA.
He was born on January 26, 1973.
He graduated from the Department of Law at Kyonggi University.
He worked as a partner attorney at Chun Chu Law Firm and joined Naturecell in 2020 as the head of legal affairs.
After the company’s owner and former CEO, Ra Jung-chan, stepped down from management, he has been leading the company together with co-CEO Kim Ju-sun.
In December 2024, he was appointed as the sole CEO of Naturecell.
As a professional manager with a background in law, he enjoys strong trust from Ra Jung-chan.
#Naturecell #ByunDaejung #stemcelltherapy #JointStem #USFDA #biotech #CEO #RaJungchan #KyonggiUniversity #lawyerCEO